Zoundream

Zoundream is revolutionizing infant care with its innovative approach to understanding and monitoring the needs of newborns. Located in Basel, Switzerland, and Barcelona, Spain, Zoundream utilizes transformative artificial intelligence and advanced sound technology to decode baby cries, offering invaluable insights to parents and pediatricians alike. Their pioneering Acoustic Multi-Stage Interpreter (AMSI) provides an accurate analysis of infant cries, enabling a deeper understanding of babies' health and emotional needs.

With a focus on continuous non-invasive monitoring, Zoundream’s technology assists in the early detection of potential neurodevelopmental disorders and other health issues, promising a new era of preventive infant healthcare. The company’s commitment to research and development is underscored by numerous clinical studies and an impressive net promoter score, reflecting high user satisfaction. Recently recognized as a Deep Tech Pioneer by Hello Tomorrow and awarded for their contributions to disease prediction, Zoundream is dedicated to enhancing parental confidence and reducing stress through effortless, data-driven solutions for child care.